A Reuters article from last week includes the sentence
That annual regulatory filing also introduced a so-called "anti-pledging" provision that prevented further loans to company directors, executives and employees using stock as collaterol.
Now, sure, this is an article about a pharmaceutical company, so maybe "collaterol" looks like an expensive new drug.
But still. Four authors, a contributor, two editors, and two updates later, and still nobody has fixed it.